which semaglutide is fda approved has a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) for long-term weight management in adults with obesity or overweight. 🔹Indication: It intended as a “step-up” therapy for The FDA-approved GLP-1 pill for

PIONEER 4-Semaglutida vs

Very easy process

Summary: Saxenda may fail to suppress appetite or cause increased hunger due to insufficient dosing, incorrect injection technique, medication storage issues, dietary composition, psychological factors, underlying medical conditions, or inadequate sleep

Medication adjustments may be considered in consultation with prescribing clinicians: Dose reduction : Lowering the Ozempic dose may reduce symptom severity whilst maintaining some glycaemic benefit Slower titration : Increasing the dose more gradually than standard protocols may improve tolerability Prokinetic agents : In the UK, medications such as metoclopramide are generally restricted to short-term use (maximum 5 days) due to neurological side effect risks